Mirati Therapeutics Inc. buy Global_Player
Start price
07.12.22
/
50%
€56.50
Target price
07.12.23
-
Performance (%)
-30.27%
End price
10.12.22
€39.40
Summary
This prediction ended on 10.12.22 with a price of €39.40. Massive losses of -30.27% were the result for the BUY prediction by Global_Player. Global_Player has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Mirati Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 0.795% | 1.458% | 17.980% | 69.888% |
| iShares Nasdaq 100 | -3.088% | -0.762% | 3.169% | 101.814% |
| iShares Nikkei 225® | -0.952% | -2.268% | 12.208% | 45.300% |
| iShares S&P 500 | -1.393% | 0.199% | 1.698% | 63.763% |
According to Global_Player what are the pros and cons of Mirati Therapeutics Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by Global_Player for this prediction
In the thread Mirati Therapeutics Inc. diskutieren
Buy Mirati Therapeutics Inc.
In the thread Trading Mirati Therapeutics Inc.
Stopped prediction by Global_Player for Mirati Therapeutics Inc.
Mirati Therapeutics Inc.
Start price
Target price
Perf. (%)
€59.10
05.10.23
05.10.23
-
05.10.24
05.10.24
-8.93%
15.10.23
15.10.23
Could be worthwhile Investment >10% per year
